GarcÃa-MarÃn, R.; Reda, S.; Riobello, C.; Cabal, V.N.; Suárez-Fernández, L.; Vivanco, B.; López, F.; Llorente, J.L.; Hermsen, M.A.
CD8+ Tumour-Infiltrating Lymphocytes and Tumour Microenvironment Immune Types as Biomarkers for Immunotherapy in Sinonasal Intestinal-Type Adenocarcinoma. Vaccines 2020, 8, 202.
https://doi.org/10.3390/vaccines8020202
AMA Style
GarcÃa-MarÃn R, Reda S, Riobello C, Cabal VN, Suárez-Fernández L, Vivanco B, López F, Llorente JL, Hermsen MA.
CD8+ Tumour-Infiltrating Lymphocytes and Tumour Microenvironment Immune Types as Biomarkers for Immunotherapy in Sinonasal Intestinal-Type Adenocarcinoma. Vaccines. 2020; 8(2):202.
https://doi.org/10.3390/vaccines8020202
Chicago/Turabian Style
GarcÃa-MarÃn, RocÃo, Sara Reda, Cristina Riobello, Virginia N. Cabal, Laura Suárez-Fernández, Blanca Vivanco, Fernando López, José L. Llorente, and Mario A. Hermsen.
2020. "CD8+ Tumour-Infiltrating Lymphocytes and Tumour Microenvironment Immune Types as Biomarkers for Immunotherapy in Sinonasal Intestinal-Type Adenocarcinoma" Vaccines 8, no. 2: 202.
https://doi.org/10.3390/vaccines8020202
APA Style
GarcÃa-MarÃn, R., Reda, S., Riobello, C., Cabal, V. N., Suárez-Fernández, L., Vivanco, B., López, F., Llorente, J. L., & Hermsen, M. A.
(2020). CD8+ Tumour-Infiltrating Lymphocytes and Tumour Microenvironment Immune Types as Biomarkers for Immunotherapy in Sinonasal Intestinal-Type Adenocarcinoma. Vaccines, 8(2), 202.
https://doi.org/10.3390/vaccines8020202
